1,720,973 research outputs found
Avaliação clínica da utilização do furosemida, maleato de enalapril, espironolactona e suas associações, em cães com endocardiose de vávula mitral
A endocardiose da válvula mitral é uma cardiopatia de alta incidência na clínica médica de pequenos animais, com maior acometimento de cães idosos e de raças de pequeno porte. Realizou-se então um estudo para avaliar clinicamente a utilização do maleato de enalapril, furosemida, espironolactona e suas associações, em cães com endocardiose de válvula mitral classes funcionais Ib e II, antes e após a terapêutica implantada. Para isso, utilizaram-se 36 animais portadores desta afecção, distribuídos em quatro grupos, conforme as classes funcionais de ICC, com terapêutica específica implantada durante 56 dias em cada grupo estudado. Animais portadores da classe funcional Ib foram distribuídos em dois grupos, com o primeiro recebendo furosemida (n=8) e o outro maleato de enalapril (n=8). Igualmente, distribuíram-se os animais da classe funcional II, com um grupo recebendo maleato de enalapril e furosemida (n=10) e o segundo, enalapril associado à espironolactona e furosemida (n=10). Todos os grupos foram avaliados em quatro momentos (T0, T14, T28 e T56 dias) quanto aos parâmetros e sinais clínicos, exames hematológicos e bioquímico-séricos, que incluíram enzima conversora da angiotensina (ECA) e aldosterona; avaliações radiográficas, eletrocardiográficas, ecodopplercardiográficas e da pressão arterial. Os resultados demonstraram uma redução dos sinais clínicos nos animais classe II, com a estabilização dos parâmetros em ambos os grupos. As avaliações hematológica e bioquímico sérica não revelaram alterações significativas nas classes estudadas, mas uma redução significativa dos valores de ECA e aldosterona foram observadas nos grupos que receberam enalapril como terapêutica. Ao exame radiográfico observou-se redução dos valores de VHS e, ao eletrocardiograma as variáveis onda Pms e Complexo QRSms apresentaram diminuições significativas...The endocardiosis of mitral valve is a high incidence of heart disease in the medical clinic for small animals, with the involvement of older dogs and small breeds. This is a clinical study to evaluate the use of the enalapril maleate, furosemide, spironolactone and their associations in dogs with mitral valve endocardiosis of class Ib and II, before and after therapy implanted. It was used 36 animals with this endocardiosis, divided into four groups according to class of congestive heart failure, implanted with a specific therapy for 56 days in each group. The animals classified in class Ib was divided into two groups, with the first receiving furosemide (n = 8) and the other of maleate of enalapril (n = 8). It is also divided the animals of Class II, with a group of receiving maleate of enalapril and furosemide (n = 10) and second, enalapril combined with spironolactone and furosemide (n = 10). Every groups were available in four moments (T0, T14, T28, e T56 days) as to clinical parameters, symptoms, serum biochemical and hematological tests, which included the angiotensin converting enzyme (ACE) and aldosterone; radiographic evaluations ECG, Dopplerechocardiography and blood pressure. The results showed a reduction of clinical signs in animals Class II, with stabilization of physiological parameters in both groups. The serum biochemical and hematological evaluation showed no significant changes in the classes studied, but a significant reduction of the values of ACE and Aldosterone were seen in the groups receiving enalapril as therapy. By radiographic examination, we observed a reduction of the values of VHS, and the variables Pms wave and QRSms Complex in electrocardiogram showed significant variations in groups of Class II. The absence of variations in blood pressure was observed in both groups. But the Dopplerechocardiogram showed a ventricular remodeling with a significant decrease... (Complete abstract click electronic access below)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES
Avaliação clínica da utilização do furosemida, maleato de enalapril, espironolactona e suas associações, em cães com endocardiose de vávula mitral
A endocardiose da válvula mitral é uma cardiopatia de alta incidência na clínica médica de pequenos animais, com maior acometimento de cães idosos e de raças de pequeno porte. Realizou-se então um estudo para avaliar clinicamente a utilização do maleato de enalapril, furosemida, espironolactona e suas associações, em cães com endocardiose de válvula mitral classes funcionais Ib e II, antes e após a terapêutica implantada. Para isso, utilizaram-se 36 animais portadores desta afecção, distribuídos em quatro grupos, conforme as classes funcionais de ICC, com terapêutica específica implantada durante 56 dias em cada grupo estudado. Animais portadores da classe funcional Ib foram distribuídos em dois grupos, com o primeiro recebendo furosemida (n=8) e o outro maleato de enalapril (n=8). Igualmente, distribuíram-se os animais da classe funcional II, com um grupo recebendo maleato de enalapril e furosemida (n=10) e o segundo, enalapril associado à espironolactona e furosemida (n=10). Todos os grupos foram avaliados em quatro momentos (T0, T14, T28 e T56 dias) quanto aos parâmetros e sinais clínicos, exames hematológicos e bioquímico-séricos, que incluíram enzima conversora da angiotensina (ECA) e aldosterona; avaliações radiográficas, eletrocardiográficas, ecodopplercardiográficas e da pressão arterial. Os resultados demonstraram uma redução dos sinais clínicos nos animais classe II, com a estabilização dos parâmetros em ambos os grupos. As avaliações hematológica e bioquímico sérica não revelaram alterações significativas nas classes estudadas, mas uma redução significativa dos valores de ECA e aldosterona foram observadas nos grupos que receberam enalapril como terapêutica. Ao exame radiográfico observou-se redução dos valores de VHS e, ao eletrocardiograma as variáveis onda Pms e Complexo QRSms apresentaram diminuições significativas...The endocardiosis of mitral valve is a high incidence of heart disease in the medical clinic for small animals, with the involvement of older dogs and small breeds. This is a clinical study to evaluate the use of the enalapril maleate, furosemide, spironolactone and their associations in dogs with mitral valve endocardiosis of class Ib and II, before and after therapy implanted. It was used 36 animals with this endocardiosis, divided into four groups according to class of congestive heart failure, implanted with a specific therapy for 56 days in each group. The animals classified in class Ib was divided into two groups, with the first receiving furosemide (n = 8) and the other of maleate of enalapril (n = 8). It is also divided the animals of Class II, with a group of receiving maleate of enalapril and furosemide (n = 10) and second, enalapril combined with spironolactone and furosemide (n = 10). Every groups were available in four moments (T0, T14, T28, e T56 days) as to clinical parameters, symptoms, serum biochemical and hematological tests, which included the angiotensin converting enzyme (ACE) and aldosterone; radiographic evaluations ECG, Dopplerechocardiography and blood pressure. The results showed a reduction of clinical signs in animals Class II, with stabilization of physiological parameters in both groups. The serum biochemical and hematological evaluation showed no significant changes in the classes studied, but a significant reduction of the values of ACE and Aldosterone were seen in the groups receiving enalapril as therapy. By radiographic examination, we observed a reduction of the values of VHS, and the variables Pms wave and QRSms Complex in electrocardiogram showed significant variations in groups of Class II. The absence of variations in blood pressure was observed in both groups. But the Dopplerechocardiogram showed a ventricular remodeling with a significant decrease... (Complete abstract click electronic access below)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES
Mensuração do volume atrial esquerdo pelo método biplanar de Simpson em cães portadores da doença mixomatosa da válvula mitral
The measurement of left atrial volume (LAV) indexed to body surface area ( ASC ) is obtained by the biplane Simpson method via echocardiography , and considered a prognostic marker in assessing left atrial cardiomyopathy and valvular heart disease in medicine . However , in dogs with myxomatous mitral valve (MMVD), valvular heart disease characterized by an overload of the left atrium (LA) , the assessment of atrial enlargement is accomplished by obtaining the LA diameter and its relation to the diameter of the aorta (Ao ) (LA:Ao) , assisting in the classification of congestive heart failure (CHF) . Therefore, we sought to measure the values for LAV indexed to ASC of healthy dogs and MMVD carriers using the biplane Simpson method. . Thus, 107 healthy dogs (control) and 81 patients with functional MMVD classes Ia, Ib and II of the CCI (ISACH) were evaluated by calculating the time of VAE in diastole (d) and systole (s) fibrillation using biplane Simpson’s method. The framework (4C) and apical two-chamber images (2C) were obtained by two-dimensional echocardiography via left parasternal (JPE) in all dogs evaluated. The values for the healthy dogs were correlated with body weight using the Linear Test Pearson and submitted to statistical normality test. In comparison with healthy carriers of MMVD dogs, as well as between functional classes of ICC, we used analysis of variance (ANOVA) and Tukey's test at p0.77) and LVAs (r > 0.73) variables with body weight in healthy dogs, with subsequent indexation of amounts on ASC and passing the normality test correlation. The values obtained using the JPE and JPD showed significant differences between the parasternal windows. The dogs with MMVD present significant differences (p0,77) e VAEs (r>0,73) com o peso corporal nos cães sadios, com posterior indexação dos valores na ASC e aprovação no teste de normalidade. Os valores obtidos utilizando a JPE e a JPD demonstraram diferenças significativas entre as janelas paraesternais. Já os cães ..
Mensuração do volume atrial esquerdo pelo método biplanar de Simpson em cães portadores da doença mixomatosa da válvula mitral
The measurement of left atrial volume (LAV) indexed to body surface area ( ASC ) is obtained by the biplane Simpson method via echocardiography , and considered a prognostic marker in assessing left atrial cardiomyopathy and valvular heart disease in medicine . However , in dogs with myxomatous mitral valve (MMVD), valvular heart disease characterized by an overload of the left atrium (LA) , the assessment of atrial enlargement is accomplished by obtaining the LA diameter and its relation to the diameter of the aorta (Ao ) (LA:Ao) , assisting in the classification of congestive heart failure (CHF) . Therefore, we sought to measure the values for LAV indexed to ASC of healthy dogs and MMVD carriers using the biplane Simpson method. . Thus, 107 healthy dogs (control) and 81 patients with functional MMVD classes Ia, Ib and II of the CCI (ISACH) were evaluated by calculating the time of VAE in diastole (d) and systole (s) fibrillation using biplane Simpson’s method. The framework (4C) and apical two-chamber images (2C) were obtained by two-dimensional echocardiography via left parasternal (JPE) in all dogs evaluated. The values for the healthy dogs were correlated with body weight using the Linear Test Pearson and submitted to statistical normality test. In comparison with healthy carriers of MMVD dogs, as well as between functional classes of ICC, we used analysis of variance (ANOVA) and Tukey's test at p0.77) and LVAs (r > 0.73) variables with body weight in healthy dogs, with subsequent indexation of amounts on ASC and passing the normality test correlation. The values obtained using the JPE and JPD showed significant differences between the parasternal windows. The dogs with MMVD present significant differences (p0,77) e VAEs (r>0,73) com o peso corporal nos cães sadios, com posterior indexação dos valores na ASC e aprovação no teste de normalidade. Os valores obtidos utilizando a JPE e a JPD demonstraram diferenças significativas entre as janelas paraesternais. Já os cães ..
Going Beyond Counting First Authors in Author Co-citation Analysis
The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
We provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Dispelling the Myths Behind First-author Citation Counts
We conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
- …
